Clinical Trials
16 trialsNCT05286632 2024-11-06
KidneYou - Innovative Digital Therapy
Advice Pharma Group srl
Phase NA Completed
NCT05799976 2024-04-25
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
Ascension Health
Phase NA Completed
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT06256172 2024-02-13
Medlink
Olawuyi Racett Nigeria Ltd
Phase NA Completed
NCT02073474 2022-12-20
An Observational Post-Marketing Safety Registry of Sativex®
Jazz Pharmaceuticals
Completed
NCT03795389 2021-09-13
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
DiaMedica Therapeutics Inc
Phase 1 Completed
NCT02000817 2019-06-24
Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
GlaxoSmithKline
Phase 1/2 Completed
NCT01637935 2018-03-07
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
Takeda
Completed
NCT02958956 2018-03-07
Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.
Takeda
Completed
NCT02958995 2018-03-07
Epidemiologic Study Of Diabetes And Cancer Risk
Takeda
Completed
NCT01236053 2017-07-06
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
Completed
NCT01138124 2017-05-30
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
GlaxoSmithKline
Completed
NCT00518102 2016-07-19
The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])
Ethicon, Inc.
Completed
NCT01235260 2016-07-19
Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Completed
NCT02608853 2015-11-20
Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADERâ„¢ Trial Participants
Novo Nordisk A/S
Completed
NCT01284608 2012-12-24
UROCOR
AstraZeneca
Completed